National Bank of Canada
PRME icon

National Bank of Canada’s Prime Medicine PRME Stock Holding History

National Bank of Canada’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-45
Closed -$24.9K – 3081
2025
Q3 		$24.9K Sell
45
-910
-95% -$3.7K ﹤0.01% 2107
2025
Q2 		$236K Buy
+955
New +$1.47K ﹤0.01% 1568
2025
Q1 		– Sell
-4
Closed -$1.17K – 3096
2024
Q4 		$1.17K Buy
+4
New +$14 ﹤0.01% 2635

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

National Bank of Canada's PRME Position: Q1 2026 in Review

National Bank of Canada opened a new position in Prime Medicine (PRME) in Q1 2026: 10 shares worth $35. The stake represents ﹤0.01% of the portfolio and ranks #2880 among its holdings. This is a return to the name: National Bank of Canada previously reported a position in PRME as recently as Q3 2025.

National Bank of Canada first reported a position in PRME in Q2 2024 and has held it in 6 quarters since. The position peaked at $244K in Q2 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • National Bank of Canada held 10 shares of Prime Medicine worth $35 as of Q1 2026.
  • Prime Medicine was a new National Bank of Canada position in Q1 2026.
  • Prime Medicine made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2880 holding.
  • National Bank of Canada first reported a position in Prime Medicine in Q2 2024 and has held it in 6 quarters since.
  • National Bank of Canada's Prime Medicine position peaked at $244K in Q2 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.